current user: public


Query: 3rgf_A mol:protein length:405 Cyclin-dependent kinase 8, from PDB0312

Results of FFAS03 search in PDB0312
Master-slave alignment does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .
# Score Template Links and tools%idFirst DKMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLKKLast
1 -127.0003rgf_A mol:protein length:405 Cyclin-dependent kinase 8  ali model  100  1DKMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLKK 405
2 -102.0003pxf_A mol:protein length:306 Cell division protein kinase 2  ali model follow..  37  4.............GSPEFMENFQKVE-KIGEGTYGVVYKAR--NKLTGEVVALKKIETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDAS-------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT----EGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD---------FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL........................................................ 306
3 -102.0003QL8 Entity 1(prereleased)  ali follow..  37  4.............GSPEFMENFQKVE-KIGEGTYGVVYKAR--NKLTGEVVALKKIETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDAS-------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT----EGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD---------FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL........................................................ 306
4 -102.0003gbz_A mol:protein length:329 Kinase, CMGC CDK  ali model follow..  36  16.......MSVSAAPSATSIDRYRRIT-KLGEGTYGEVYKAIDT--VTNETVAIKRIEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HRLHLIFEYAENDLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAETPVLKIGDFGLARAFGIPIRQF---THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---------DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL--------KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD.............................................................. 322
5 -102.0002pk9_A mol:protein length:317 Cyclin-dependent protein kinase PHO85  ali model follow..  33  2................SSSSQFKQLE-KLGNGTYATVYKGLNK--TTGVYVALKEVKEEGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKLTLVFEFMDNDLKKYMDSRTVGNTPRG---LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK----RGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---------EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ----PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGSRS...................................................... 311
6 -102.0001gii_A mol:protein length:298 CELL DIVISION PROTEIN KINASE 2  ali model follow..  38  1..................MENFQKVE-KIGEGTYGVVYKAR--NKLTGEVVALKKIETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEHVHQDLKTFMDAS-------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT----EGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD---------FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL........................................................ 298
7 -101.0001vyw_A mol:protein length:309 CELL DIVISION PROTEIN KINASE 2  ali model follow..  37  3...............LVDMENFQKVE-KIGEGTYGVVYKAR--NKLTGEVVALKKIETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDAS-------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT----EGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD---------FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRLERPHR................................................... 308
8 -101.0001ua2_A mol:protein length:346 Cell division protein kinase 7  ali model follow..  34  1..........MALDVKSRAKRYEKLD-FLGEGQFATVYKARDKN--TNQIVAIKKIAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVFDFMETDLEVIIK--------DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE----NGVLKLADFGLAKSFGSPNRAY---THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---------DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP----------LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKK.................... 343
9 -101.0002qkr_A mol:protein length:313 Cdc2-like CDK2/CDC28 like protein kinase  ali model follow..  37  3.......SGRENLYFQGLMEKYQKLE-KVGEGTYGVVYKAKDS---QGRIVALKRIEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTLVFEFMEKDLKKVLD--------ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS----DGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---------DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEK--------KPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQI............................................................. 305
10 -99.9003mi9_A mol:protein length:351 Cell division protein kinase 9  ali model follow..  31  3.....KQYDSVECPFCDEVSKYEKLA-KIGQGTFGEVFKAR--HRKTGQKVALKKVEKEGFPITALREIKILQLLKHENVVNLIEICRTKASGSIYLVFDFCEHDLAGLLS--------NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR----DGVLKLADFGLARAFSLAKNS-NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---------HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR------DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRK...................................... 345
11 -99.8001h4l_A mol:protein length:292 CELL DIVISION PROTEIN KINASE 5  ali model follow..  39  1..................MQKYEKLE-KIGEGTYGTVFKAKNR--ETHEIVALKRVDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFD--------SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR----NGELKLADFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANARPLFPGNDVD---------DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS---------LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP.............................................................. 292
12 -99.8001ob3_A mol:protein length:288 CELL DIVISION CONTROL PROTEIN 2 HOMOLOG  ali model follow..  39  1..................MEKYHGLE-KIGEGTYGVVYKAQNN---YGETFALKKIEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLD--------VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR----EGELKIADFGLARAFGIPVRKY---THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---------DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP---------WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE.................................................................. 286
13 -98.9003mtl_A mol:protein length:324 Cell division protein kinase 16  ali model follow..  37  1..................METYIKLD-KLGEGTYATVYKGKSK--LTDNLVALKEIREEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVFEYLDKDLKQYLD--------DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE----RGELKLADFGLARAKSIPTKTY---DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---------EQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRA--------EALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK........................................................... 294
14 -98.2004aaa_A mol:protein length:331 CYCLIN-DEPENDENT KINASE-LIKE 2  ali model follow..  30  7.......DLGTENLYFQSMEKYENLG-LVGEGSYGMVMKCRNKD--TGRIVAIKKFDDKMVKKIAMREIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNG--------LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ----SGVVKLCDFGFARTLAAPGEVY---DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---------DQLYHIMMCLGNLIPRHQELFNKNPVFAGV-------RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKV................................................... 321
15 -97.5001bi7_A mol:protein length:326 CYCLIN-DEPENDENT KINASE 6  ali model follow..  33  3...........KDGLCRADQQYECVA-EIGEGAYGKVFKARDLK-NGGRFVALKRVGEEGMPLSTIREVAVLRHLEHPNVVRLFDVCTVSRETKLTLVFEHVDQDLTTYLDKV-------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS----SGQIKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDV---------DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS-----------AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSELNTA.......................................... 326
16 -95.9003nup_A mol:protein length:307 Cell division protein kinase 6  ali model follow..  35  3...........KDGLCRADQQYECVA-EIGEGAYGKVFKARDLK-NGGRFVALKRVGEEGMPLSTIREVAVLRHLEHPNVVRLFDVCTVSRETKLTLVFEHVDQDLTTYLDKV-------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS----SGQIKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDV---------DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS-----------AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ................................................................... 301
17 -95.4003g33_A mol:protein length:308 Cell division protein kinase 4  ali model follow..  37  3.............LGSMATSRYEPVA-EIGVGAYGTVYKAR--DPHSGHFVALKSVRGGGLPISTVREVALLRRLEHPNVVRLMDVCATSREIKVTLVFEHVDQDLRTYLDKA-------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS----GGTVKLADFGLARIYSYQMA----LTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEA---------DQLGKIFDLIGLPPEDDWPRDVSLPRGA-----------FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKEGNP.............................................................. 307
18 -95.3002w96_B mol:protein length:306 CELL DIVISION PROTEIN KINASE 4  ali model follow..  38  2.................ATSRYEPVA-EIGVGAYGTVYKAR--DPHSGHFVALKSVGEEGLPISTVREVALLRRLEHPNVVRLMDVCATSREIKVTLVFEHVDQDLRTYLDKA-------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS----GGTVKLADFGLARIYSYQMA----LDPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEA---------DQLGKIFDLIGLPPEDDWPRDVSLPRGA-----------FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE................................................................ 296
19 -94.9004agu_A mol:protein length:311 CYCLIN-DEPENDENT KINASE-LIKE 1  ali model follow..  32  1.................MMEKYEKIG-KIGEGSYGVVFKCRNRD--TGQIVAIKKFDDPVIKKIALREIRMLKQLKHPNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQR--------GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH----SVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV---------DQLYLIRKTLGDLIPRHQQVFSTNQYFSGV-------KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAE.................................................. 306
20 -81.6002i6l_A mol:protein length:320 Mitogen-activated protein kinase 6  ali model follow..  29  11...................SRYMDL-KPLGCGGNGLVFSA--VDNDCDKRVAIKKITDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSNSVYIVQEYMETDLANVLEQG----------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV---LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---------EQMQLILESIPVVHEEDRQELSVIPVYIRNDMTEPHKP---------LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE........................................................... 318
21 -79.3003SAY Entity 1(prereleased)  ali follow..  28  51................PQEVSYTDT-KVIGNGSFGVVYQAKLCD--SGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKLNLVLDYVPETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLCDFGSAKQL----VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---------DQLVEIIKVLGTPTREQIREMN---------PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK........................................................... 349
22 -79.0001o9u_A mol:protein length:350 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  28  17................PQEVSYTDT-KVIGNGSFGVVYQAKLCD--SGELVAIKKVLQG--KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKLNLVLDYVPATVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLCDFGSAKQL----VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---------DQLVEIIKVLGTPTREQIREMN---------PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK........................................................... 315
23 -78.2001gng_A mol:protein length:378 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  28  26................PQEVSYTDT-KVIGNGSFGVVYQAKLCD--SGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKLNLVLDYVPETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLCDFGSAKQL----VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---------DQLVEIIKVLGTPTREQIREMN---------PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK........................................................... 324
24 -78.0001r0e_A mol:protein length:391 Glycogen synthase kinase-3 beta  ali model follow..  28  22................PQEVSYTDT-KVIGNGSFGVVYQAKLCD--SGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKLNLVLDYVPETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLCDFGSAKQL----VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---------DQLVEIIKVLGTPTREQIREMN---------PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK........................................................... 320
25 -77.9001q3d_A mol:protein length:424 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  28  55................PQEVSYTDT-KVIGNGSFGVVYQAKLCD--SGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKLNLVLDYVPETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLCDFGSAKQL----VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---------DQLVEIIKVLGTPTREQIREMN---------PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK........................................................... 353
26 -77.9004dit_A mol:protein length:382 Glycogen synthase kinase-3 beta  ali model follow..  28  29................PQEVSYTDT-KVIGNGSFGVVYQAKLCD--SGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKLNLVLDYVPETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLCDFGSAKQL----VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---------DQLVEIIKVLGTPTREQIREMN---------PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK........................................................... 327
27 -76.4003e3p_A mol:protein length:360 Protein kinase, putative Glycogen synthase ki  ali model follow..  29  20................KEMDRFQVE-RMAGQGTFGTVQLGKEKS--TGMSVAIKKVQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDLNVVMEYVPDTLHRCCRNYYRRQVA-----PPPILIKVFLFQLIRSIGCLHSVNVCHRDIKPHNVLVNEA---DGTLKLCDFGSAKKLSPS----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---------GQLHEIVRVLGCPSREVLRKLNP-------HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK........................................................... 327
28 -76.0002pvh_A mol:protein length:352 Casein kinase II subunit alpha  ali model follow..  24  44.................EQDDYEVV-RKVGRGKYSEVFEG--INVNNNEKCIIKILKPV--KKKIKREIKILQNLGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFY----HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKPFFYGHDNH---------DQLVKIAKVLGTDGLNAYLNKYRIPQLEALVGRHSRKPWLKFMN----ADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENS........................................................... 342
29 -75.4003eb0_A mol:protein length:383 Putative uncharacterized protein  ali model follow..  24  4................TSSKKYSLG-KTLGTGSFGIVCEV--FDIESGKRFALKKVLQD--PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEELNVIMEYVPDTLHKVLKSFIRSGR-----SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK---DNTLKLCDFGSAKKL----IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI---------DQLVRIIQIMGTPTKEQMIRMN---------PHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYES........................................................... 334
30 -75.4003e3b_X mol:protein length:339 Casein kinase II subunit alpha`  ali model follow..  25  41.................NQDDYQLV-RKLGRGKYSEVFEA--INITNNERVVVKILKPVK-KKKIKREVKILENLRGTNIIKLIDTVKDPVSKTPALVFEYINTDFKQLYQ------------ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ---QKKLRLIDWGLAEFY----HPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRRPFFHGQDNY---------DQLVRIAKVLGTEELYGYLHIDLDPHFNDILGQHSRKRWENFIH----SENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ........................................................... 339
31 -74.1002zjw_A mol:protein length:340 Casein kinase II subunit alpha  ali model follow..  25  40.................NQDDYQLV-RKLGRGKYSEVFEA--INITNNEKVVVKILKPV--KKKIKREIKILENLRGPNIITLADIVKDPVSRTPALVFEHVNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE---HRKLRLIDWGLAEFY----HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKPFFHGHDNY---------DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS-RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQAR........................................................... 338
32 -74.1002b9f_A mol:protein length:353 Mitogen-activated protein kinase FUS3  ali model follow..  29  11...................SDFQLK-SLLGEGAYGVVCSA--THKPTGEIVAIKKIDKPLFALRTLREIKILKHFKHENIITIFNIQRPENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD----LKVCDFGLARIIDESAADNSEMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD---------YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP------AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE........................................................... 318
33 -73.8003rp9_A mol:protein length:458 Mitogen-activated protein kinase  ali model follow..  32  53...................DRYEIR-HLIGTGSYGHVCEA--YDKLEKRVVAIKKIEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVDELYVVLEIADSDFKKLFRT---------PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-----SVKVCDFGLARTVDYPENGNSQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNRGPLFPGSSNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK-------EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRY................................... 433
34 -73.8003ofm_A mol:protein length:350 Casein kinase II subunit alpha`  ali model follow..  24  36.................NQDDYQLV-RKLGRGKYSEVFEA--INITNNERVVVKILKPV--KKKIKREVKILENLRGTNIIKLIDTVKDPVSKTPALVFEYINTDFKQLYQ------------ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ---QKKLRLIDWGLAEFY----HPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRRPFFHGQDNY---------DQLVRIAKVLGTEELYGY-HIDLDPHFNDILGQHSRKRWENFIH----SENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSS................................................. 344
35 -73.1003QYI Entity 1(prereleased)  ali follow..  33  21...................PRYTNL-SYIGEGAYGMVCSA--YDNLNKVRVAIKKIEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQVYIVQDLMETDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILGSPSQEDLNCIIN-------LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD................................................. 330
36 -73.0002ojg_A mol:protein length:380 Mitogen-activated protein kinase 1  ali model follow..  33  37...................PRYTNL-SYIGEGAYGMVCSA--YDNVNKVRVAIKKIEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQVYIVQDLMETDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILGSPSQEDLNCIIN-------LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD................................................. 346
37 -73.0001pme_A mol:protein length:380 ERK2  ali model follow..  33  37...................PRYTNL-SYIGEGAYGMVCSA--YDNVNKVRVAIKKIEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQVYLVTHLMGADLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILGSPSQEDLNCIIN-------LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD................................................. 346
38 -72.8003fv8_A mol:protein length:355 Mitogen-activated protein kinase 10  ali model follow..  30  21................TVLKRYQNL-KPIGSGAQGIVCAA--YDAVLDRNVAIKKLQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTQDVYLVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQLGTPCPEFMKKLQTVRNYVENRPKYAGLTFPKLFPDSADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA............................................................. 328
39 -72.5002z7l_A mol:protein length:366 Mitogen-activated protein kinase 1  ali model follow..  33  23...................PRYTNL-SYIGEGAYGMVCSA--YDNLNKVRVAIKKIEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQVYIVQDLMETDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILGSPSQEDLNCIIN-------LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD................................................. 332
40 -72.4003rp0_A mol:protein length:349 Casein kinase II subunit alpha, Casein kinase  ali model follow..  25  35.................NQDDYQLV-RKLGRGKYSEVFEA--INITNNEKVVVKILKPV--KKKIKREIKILENLRGPNIITLADIVKDPVSRTPALVFEHVNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE---HRKLRLIDWGLAEFY----HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKPFFHGHDNY---------DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS-RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPCADNAVLSS................................................. 343
41 -72.4001wzy_A mol:protein length:368 Mitogen-activated protein kinase 1  ali model follow..  33  31...................PRYTNL-SYIGEGAYGMVCSA--YDNVNKVRVAIKKIEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQVYIVQDLMETDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILGSPSQEDLNCIIN-------LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD................................................. 340
42 -72.3003UIB Entity 1(prereleased)  ali follow..  26  22...................SPYTVQ-RFISSGSYGAVCAGVDS---EGIPVAIKRVSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEHKLYLVTELMRTDLAQVIHD--------QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND----ITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---------FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP------ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL........................................................... 329
43 -72.3003pg1_A mol:protein length:362 Mitogen-activated protein kinase, putative (M  ali model follow..  26  22...................SPYTVQ-RFISSGSYGAVCAGVDS---EGIPVAIKRVSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEHKLYLVTELMRTDLAQVIHD--------QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND----ITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---------FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP------ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL........................................................... 329
44 -72.2003oz6_A mol:protein length:388 Mitogen-activated protein kinase 1, serine/th  ali model follow..  32  6................HVLRKYELV-KKLGKGAYGIVWKS--IDRRTGEVVAVKKIQNSTDAQRTFREIMILTELSHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-----HVKVADFGLSRSFVNIRRVTNNLTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS---------TMNQLERIIGVIDFPSNEDVESIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRN................................... 365
45 -72.1001tvo_A mol:protein length:368 Mitogen-activated protein kinase 1  ali model follow..  33  23...................PRYTNL-SYIGEGAYGMVCSA--YDNVNKVRVAIKKIEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQVYIVQDLMETDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILGSPSQEDLNCIIN-------LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD................................................. 332
46 -72.1002zoq_A mol:protein length:382 Mitogen-activated protein kinase 3  ali model follow..  35  43...................PRYTQL-QYIGEGAYGMVSSA--YDHVRKTRVAIKKIEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLRDVYIVQDLMETDLYKLLKSQ----------QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTT-----DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILGSPSQEDLNCIIN-------MKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFA................................................. 352
47 -71.1001cm8_A mol:protein length:367 PHOSPHORYLATED MAP KINASE P38-GAMMA  ali model follow..  31  25...................AVYRDL-QPVGSGAYGAVCSA--VDGRTGAKVAIKKLQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETTDFYLVMPFMGTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-----ELKILDFGLARQAD------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---------HLDQLKEIMKVTGTPPAEFVQRLQS-------DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE........................................................... 320
48 -71.0003e7o_A mol:protein length:360 Mitogen-activated protein kinase 9  ali model follow..  29  22...................KRYQQL-KPIGSGAQGIVCAA--FDTVLGINVAVKKLQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTQDVYLVMELMDANLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----TLKILDFGLARTASTNFM----MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTD---------HIDQWNKVIEQLGTPSAEFMAALQTVRNYVENRPAYPGIAFEELFPDPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP....................................................... 332
49 -71.0003gcp_A mol:protein length:360 Mitogen-activated protein kinase 14  ali model follow..  33  22...................ERYQNL-SPVGSGAYGSVCAA--FDTKTGLRVAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSNDVYLVTHLMGADLNNIVKSQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLCRHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRLVGTPGAELLKKISS-------ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE........................................................... 317
50 -70.9002g01_A mol:protein length:370 Mitogen-activated protein kinase 8  ali model follow..  27  24...................KRYQNL-KPIGSGAQGIVCAA--YDAILERNVAIKKLQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSQDVYIVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----TLKILDFGLARTAGTS----FMMEPEVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRD---------YIDQWNKVIEQLGTPCPEFMKKLQTVRTYVENRPKYAGYSFEKLFPDVADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP....................................................... 334
51 -70.9003e92_A mol:protein length:371 Mitogen-activated protein kinase 14  ali model follow..  33  33...................ERYQNL-SPVGSGAYGSVCAA--FDTKTGLRVAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRLVGTPGAELLKKISS-------ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE........................................................... 328
52 -70.8002fsl_X mol:protein length:367 Mitogen-activated protein kinase 14  ali model follow..  33  23...................ERYQNL-SPVGSGAYGSVCAA--FDTKTGLRVAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLARHTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRLVGTPGAELLKKISS-------ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE........................................................... 318
53 -70.8003U8W Entity 1(prereleased)  ali follow..  33  28...................ERYQNL-SPVGSGAYGSVCAA--FDTKTGLRVAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRLVGTPGAELLKKISS-------ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE........................................................... 323
54 -70.8003p4k_A mol:protein length:370 Mitogen-activated protein kinase 14  ali model follow..  33  26...................ERYQNL-APVGSGAYGSVCAA--FDTKTGHRVAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRLVGTPGAELLKKISS-------ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE........................................................... 321
55 -70.8003oht_A mol:protein length:389 p38a  ali model follow..  32  45...................ERYQTL-SPVGSGAYGSVCSS--YDVKSGLKIAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD---------HINQLQQIMRLTGTPPASVISRMPS-------HEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE........................................................... 340
56 -70.8003gc8_A mol:protein length:370 Mitogen-activated protein kinase 11  ali model follow..  31  28...................QRLQGL-RPVGSGAYGSVCSA--YDARLRQKVAVKKLQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSSEVYLVTTLMGADLNNIVKCQ----------ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-----ELRILDFGLARQAD------EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD---------YIDQLKRIMEVVGTPSPEVLAKISS-------EHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE........................................................... 323
57 -70.7003coi_A mol:protein length:353 Mitogen-activated protein kinase 13  ali model follow..  31  24...................KTYVSP-THVGSGAYGSVCSA--IDKRSGEKVAIKKLQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSYDFYLVMPFMQTDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-----ELKILDFGLARHAD------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---------YLDQLTQILKVTGVPGTEFVQKLND-------KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDS................................................. 328
58 -70.7003dt1_A mol:protein length:383 Mitogen-activated protein kinase 14  ali model follow..  33  39...................ERYQNL-SPVGSGAYGSVCAA--FDTKTGLRVAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRLVGTPGAELLKKISS-------ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE........................................................... 334
59 -70.7001oz1_A mol:protein length:372 Mitogen-activated protein kinase 14  ali model follow..  33  28...................ERYQNL-SPVGSGAYGSVCAA--FDTKTGLRVAVKKLQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-----ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRLVGTPGAELLKKISS-------ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE........................................................... 323
60 -70.6003n9x_A mol:protein length:432 Phosphotransferase  ali model follow..  30  20...................DNYIIK-HLIGRGSYGYVYLA--YDKNTEKNVAIKKVEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLDELYIVLEIADSDLKKLFKT---------PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-----SVKVCDFGLARTINSEKDTNIVLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNRFPLFPGSSNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK-------PEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRY................................... 392
61 -70.6002xrw_A mol:protein length:371 MITOGEN-ACTIVATED PROTEIN KINASE 8  ali model follow..  27  25...................KRYQNL-KPIGSGAQGIVCAA--YDAILERNVAIKKLQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSQDVYIVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----TLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVIEQLGTPCPEFMKKLQTVRTYVENRPKYAGYSFEKLFPDVADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP....................................................... 335
62 -70.5003npc_A mol:protein length:364 Mitogen-activated protein kinase 9  ali model follow..  29  22.................VLKRYQQL-KPIGSGAQGIVCAA--FDTVLGINVAVKKLQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTQDVYLVMELMDANLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----TLKILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTD---------HIDQWNKVIEQLGTPSAEFMAALQTVRNYVENRPKYPGIKFEELFPDWSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP....................................................... 334
63 -70.4003elj_A mol:protein length:369 Mitogen-activated protein kinase 8  ali model follow..  27  29...................KRYQNL-KPIGSGAQGIVCAA--YDAILERNVAIKKLQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSQDVYIVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----TLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRD---------YIDQWNKVIEQLGTPCPEFMKKLQTVRTYVENRPKYAGYSFEKLFPDVADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP....................................................... 339
64 -70.2003tti_A mol:protein length:464 Mitogen-activated protein kinase 10  ali model follow..  29  62...................KRYQNL-KPIGSGAQGIVCAA--YDAVLDRNVAIKKLQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTQDVYLVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----TLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQLGTPCPEFMKKLQTVRNYVENRPKYAGLTFPKLFPDSADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP....................................................... 372
65 -70.2003nie_A mol:protein length:429 MAP2 kinase  ali model follow..  31  22...................DNYEIK-HLIGRGSYGYVYLA--YDKNANKNVAIKKVEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLDELYIVLEIADSDLKKLFKT---------PIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQD-----SVKICDFGLARTINSDKDIHIVLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNRFPLFPGSSNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITK-------QEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMVLSETQLRY................................... 397
66 -69.6002xs0_A mol:protein length:386 MITOGEN-ACTIVATED PROTEIN KINASE 8  ali model follow..  28  24.................VLKRYQNL-KPIGSGAQGIVCAA--YDAILERNVAIKKLQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSQDVYIVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-----TLKILDFGLARTAGTS----FMMVPFVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVIEQLGTPCPEFMKKLQTVRTYVENRPKYAGYSFEKLFPDVADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP....................................................... 336
67 -54.0003cek_A mol:protein length:313 Dual specificity protein kinase TTK  ali model follow..  21  25.......................SILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLNEIAYLNKLQQDKIIRLYDYE--ITDQYIYMVMECGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLIDFGIANQMQPDTTSVV-KDSQVGTVNYMPPEAIKDMSKISPKSDVWSLGCILYYMTYGKTPFQQII-----------NQISKLHAIIDPNHEIEFPDI---------------------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE................................................... 307
68 -53.0002zmc_A mol:protein length:390 Dual specificity protein kinase TTK  ali model follow..  22  53.......................SILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLNEIAYLNKLQQDKIIRLYDYE--ITDQYIYMVMECGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLIDFGIANQMQPDTTSVV-KDSQVGTVNYMPPEAIKDMSKISPKSDVWSLGCILYYMTYGKTPFQQII-----------NQISKLHAIIDPNHEIEFPDI---------------------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP.............................................................. 324
69 -53.0002a19_B mol:protein length:284 Interferon-induced, double-stranded RNA-activ  ali model follow..  24  7...............KRFGMDFKEI-ELIGSGGFGQVFKAKHR--IDGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWDGFKTKCLFIQMEFCDKTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT----KQVKIGDFGLVTSLKND----GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD------------------------GIISDI---------------------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK.................................................................. 273
70 -52.3001zxe_A mol:protein length:303 Serine/threonine-protein kinase  ali model follow..  24  3................RYASDFEEI-AVLGQGAFGQVVKARNA--LDSRYYAIKKIRHTEEKLSTISEVMLLASLNHQYVVRYYAAWLERKKSTLFIQMEYCE-TLYDLIH--------SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPMNIFIDES----RNVKIGDFGLAKNVHRSLDILDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---------------FSTGMERVNILKKLRSVSIEFPPDFDD------------------------------NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV.................................................................. 289
71 -51.9002jav_A mol:protein length:279 SERINE/THREONINE-PROTEIN KINASE NEK2  ali model follow..  25  2...............PSRAEDYEVL-YTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE-DLASVITKGTKERQY-----LDEEFVLRVMTQLTLALKECHRHTVLHRDLKPANVFLDGK----QNVKLGDFGLARILNHDTS----AKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMP-------------PFTAFSQKELAGKIREGK------FRRIPYR---------------------------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE.................................................................. 273
72 -51.6003p1a_A mol:protein length:311 Membrane-associated tyrosine- and threonine-s  ali model follow..  23  50..................QQSFQRL-SRLGHGSYGEVFKVRSKE--DGRLYAVKRSMSPFRGPKKLAEVGSHEKVQHPCCVRLEQAW--EEGGILYLQTELCGPSLQQHCE--------AWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR----GRCKLGDFGLLVELGTAGAGEV----QEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNMEL------------PHGGEGWQQLRQGYLPP------------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ.................................................................. 304
73 -51.3003cok_A mol:protein length:278 Serine/threonine-protein kinase PLK4  ali model follow..  25  14.......................KVGNLLGKGSFAGVYRAE--SIHTGLEVAIKMIDKKAMYKAGMNEVKIHCQLKHPSILELYNYF--EDSNYVYLVLEMCHNEMNRYLKNRVKP--------FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN----IKIADFGLATQLKMPHEKHYTLCG---TPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRP-------------PFDTDTVKNTLN-------KVVLADYEMPSF---------------------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR.................................................................. 268
74 -51.0002wtk_C mol:protein length:305 SERINE/THREONINE-PROTEIN KINASE 11  ali model follow..  23  1...............AKLIGKYL-MGDLLGEGSYGKVKEVL--DSETLCRRAVKILKKKKLRRIP-KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-------FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG----GTLKISALGVAEALH-PFAADDTCRTSQGSPAFQPPEIANGLDTFGFKVDIWSAGVTLYNITTGL-------------YPFEGDNIYKLFENIGK-------GSYAIPGD---------------------------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK.................................................................. 269
75 -50.8001z57_A mol:protein length:339 Dual specificity protein kinase CLK1  ali model follow..  22  14...................ARYEIVDT-LGEGAFGKVVECIDHKA-GGRHVAVKIVKNDRYCEAARSEIQVLEHLNTTRCVQMLEWFEHH--GHICIVFELLGLSTYDFIK-------ENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYINPDIKVVDFGSATYDDEHHSTL------VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDS---------KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI............................................................. 339
FFAS is supported by the NIH grant R01-GM087218-01
4 7 3 1 3   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
 Locations of visitors to this page
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Grynberg M, Erlandsen H, Godzik A. HEPN: a common domain in bacterial drug resistance and human neurodegenerative proteins. Trends Biochem Sci. 2003 May;28(5):224-6. Review.